2024
Mental Health Issues in Adults with Autism Spectrum Disorders
Volkmar F, Grindle H, Solomon C, O’Brian S, Øien R. Mental Health Issues in Adults with Autism Spectrum Disorders. 2024, 329-349. DOI: 10.1007/978-3-031-46463-8_13.Peer-Reviewed Original ResearchMental health issuesResults of treatment studiesRates of anxietyAutism spectrum disorderMental health problemsMental health conditionsPsychotherapeutic treatmentPsychological treatmentSuicidal thinkingSuicidal actionSpectrum disorderSubstance abuseTreatment studiesPsychological careOlder adultsEvidence-based treatment guidelinesAutismASDMiddle-agedAdultsHealth issuesModel of researchHealth problemsTreatment guidelinesMultiple needsAutism Spectrum Disorder in Adolescents and Adults: An Introduction
Volkmar F, Reichow B, McPartland J. Autism Spectrum Disorder in Adolescents and Adults: An Introduction. 2024, 1-16. DOI: 10.1007/978-3-031-46463-8_1.Peer-Reviewed Original Research
2021
Bullying & Autism and Related Disorders
Volkmar F, Pete B. Bullying & Autism and Related Disorders. 2021, 199-217. DOI: 10.1007/978-3-030-70913-6_9.Peer-Reviewed Original Research
2015
A Brief History of Autism
Volkmar F. A Brief History of Autism. Contemporary Clinical Neuroscience 2015, 3-14. DOI: 10.1007/978-1-4939-2190-4_1.Peer-Reviewed Original Research
2014
Autism Spectrum Disorder in Adolescents and Adults: An Introduction
Volkmar F, Reichow B, McPartland J. Autism Spectrum Disorder in Adolescents and Adults: An Introduction. 2014, 1-13. DOI: 10.1007/978-1-4939-0506-5_1.Peer-Reviewed Original Research
2001
Speech and Prosody Characteristics of Adolescents and Adults With High-Functioning Autism and Asperger Syndrome
Shriberg L, Paul R, McSweeny J, Klin A, Cohen D, Volkmar F. Speech and Prosody Characteristics of Adolescents and Adults With High-Functioning Autism and Asperger Syndrome. Journal Of Speech Language And Hearing Research 2001, 44: 1097-1115. PMID: 11708530, DOI: 10.1044/1092-4388(2001/087).Peer-Reviewed Original ResearchConceptsHigh functioning autismPervasive developmental disorderAsperger syndromeDevelopmental disordersMale speakersGroups of speakersAffective aspectsTypical speakersProsody characteristicsSocial sourcesDiscourse constraintsSpeakersAutismSpeechUtterancesMore participantsDistortion errorsAge rangeProsodyDisordersAdolescentsFindingsParticipantsPhrasingAdults
1999
Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders
Volkmar F, Cook E, Pomeroy J, Realmuto G, Tanguay P, Issues T. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 32s-54s. PMID: 10624084, DOI: 10.1016/s0890-8567(99)80003-3.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderDevelopmental disordersRelated pervasive developmental disordersPatterns of delayCognitive skillsBehavioral problemsSyndrome expressionTreatment of childrenAutismCoordination of servicesPractice parametersTreatment modalitiesSustained interventionsMental retardationIndividualsDisordersClinical careAdolescentsDevianceSkillsFirst yearChildrenCareAdultsIntervention
1996
A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder
McDougle C, Naylor S, Cohen D, Volkmar F, Heninger G, Price L. A Double-blind, Placebo-Controlled Study of Fluvoxamine in Adults With Autistic Disorder. JAMA Psychiatry 1996, 53: 1001-1008. PMID: 8911223, DOI: 10.1001/archpsyc.1996.01830110037005.Peer-Reviewed Original ResearchConceptsStudy of FluvoxamineAutistic disorderSelective serotonin uptake inhibitorAdverse cardiovascular eventsPlacebo-controlled trialWeeks of treatmentSerotonin uptake inhibitorSerotonin neurotransmitter systemShort-term treatmentCardiovascular eventsPlacebo groupMild sedationNeurotransmitter systemsTreatment responseSafe drugUptake inhibitorFluvoxamineSymptoms of autismFluvoxamine maleateDisordersPlaceboAutistic behaviorPatientsAdultsSymptoms
1992
Clomipramine in Autism: Preliminary Evidence of Efficacy
MCDOUGLE C, PRICE L, VOLKMAR F, GOODMAN W, WARD-O'BRIEN D, NIELSEN J, BREGMAN J, COHEN D. Clomipramine in Autism: Preliminary Evidence of Efficacy. Journal Of The American Academy Of Child & Adolescent Psychiatry 1992, 31: 746-750. PMID: 1644740, DOI: 10.1097/00004583-199207000-00025.Peer-Reviewed Original ResearchConceptsAutistic disorderPreliminary evidenceObsessive-compulsive symptomsSocial relatednessImpulsive behaviorCompulsive symptomsEfficacy of clomipramineYoung adultsPrevious evidenceClomipramine treatmentSerotonin neurotransmissionDisordersAutismClomipramineSymptomsTreatmentEfficacySignificant improvementAdultsEvidenceOutpatientsPathophysiologyNeurotransmissionRelatednessFindings
1991
Thought disorder in high-functioning autistic adults
Dykens E, Volkmar F, Glick M. Thought disorder in high-functioning autistic adults. Journal Of Autism And Developmental Disorders 1991, 21: 291-301. PMID: 1938775, DOI: 10.1007/bf02207326.Peer-Reviewed Original ResearchConceptsThought disorderTLC scaleAutistic subjectsAutistic young adultsPoor reality testingAutistic adultsCognitive slippageRorschach inkblotsPerceptual distortionRorschach resultsReality testingOlder adolescentsRorschach protocolsDisorder ScaleObjective ratingsYoung adultsNegative featuresProjective dataSchizophreniaDisordersAreas of similarityAdultsAutismInkblotsRorschach
1986
Compliance, Noncompliance, and Negativism
Volkmar F. Compliance, Noncompliance, and Negativism. Current Issues In Autism 1986, 171-188. DOI: 10.1007/978-1-4899-2242-7_9.Peer-Reviewed Original ResearchPreferential interestResponsive social environmentSelf-regulatory behaviorsImportant developmental phenomenonCognitive sophisticationCourse of developmentLanguage developmentSocial interactionSocial engagementExtensive trainingDevelopmental phenomenaSocial environmentProsocialImitationGazeInfantsAbilityParticipantsSecond yearNegativismCaregiversTrainingEngagementAdultsImportant prerequisite